Ireland
--:--IST
Latest
Clinical Trials in Portugal / NCT04288531
Active, not recruiting Observational

Iodine Impact on Thyroid Function and Psychomotor Development, Observational Study in the Portuguese Minho Region

NCT04288531 · tracked via the Priya Life Science Portugal tracker
Phase
Observational
Started
2020-01-10
Last updated
2024-11-15

Condition(s) studied

Iodine DeficiencyThyroidPregnancy RelatedPsychomotor ImpairmentHypothyroidism in PregnancyNutrient Deficiency

Investigational drug(s) / intervention(s)

Iodine supplementation

Iodine supplementation: Recommendation, issued by the National Health Authorities, on supplementing with iodine (200 ug/day) women during preconception, pregnancy and lactation.

Study summary

Full intellectual capabilities are achieved only if crucial nutrients are present during development. Iodine deficiency is the most common cause of preventable brain harm in infants. Because of its critical need during pregnancy, several countries implemented programs of iodine supplementation in preconception and pregnancy. In 2013, the prevalence of iodine deficiency in Portugal has led health authorities to issue a recommendation for iodine supplementation. This study aims to evaluate the impact of iodine supplementation on maternal and fetal iodine status and thyroid function, obstetric outcomes, quality of breast milk and child psychomotor development. It also intends to evaluate whether the time of iodine supplementation initiation influences all the above-mentioned parameters. The novelty and relevance of this study reside on the number of women/child and on the extent of health parameters that will be evaluated. The information collected will contribute to the detailed characterization of thyroid hormone homeostasis throughout pregnancy and its relationship with iodine supplementation (including time of initiation). The data will provide evidence on whether this iodine supplementation strategy impacted on iodine sufficiency of the mother and the newborns, or if it needs re-evaluation.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
50 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Women of who intend to become pregnant or are pregnant, able to read, write and provide informed consent Exclusion Criteria: * Women transferred from outside the study health centres during pregnancy and women taking iodine supplementation before recruitment. * Women not intending to deliver at Hospital de Braga.

Primary outcome measure(s)

Trial sites (10)

FacilityCityRegionStatus
Usf Maxisaude Braga Portugal
Usf Braga Norte Braga Portugal
Usf Ruães Braga Portugal
Usf S. Lourenço Braga Portugal
Usf Gualtar Braga Portugal
Usf + Carandá Braga Portugal
Usf Manuel Rocha Peixoto Braga Portugal
Usf Bracara Augusta Braga Portugal
Usf Do Minho Braga Portugal
Usf S. João de Braga Braga Portugal

More University of Minho trials in Portugal

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04288531 on ClinicalTrials.gov ↗ ← All trials in Portugal